<DOC>
	<DOCNO>NCT00348764</DOCNO>
	<brief_summary>To evaluate efficacy tolerance echoguided sclerotherapy use Lauromacrogol 400 foam treatment Great Saphenous Vein ( GSV ) insufficiency . A comparative study 3 % versus 1 % Lauromacrogol 400 foam .</brief_summary>
	<brief_title>ESGVS : Sclerotherapy With Lauromacrogol</brief_title>
	<detailed_description>A multicenter randomize double blind study evaluate efficacy tolerance echoguided sclerotherapy use 3 % versus 1 % Lauromacrogol 400 foam treatment Great Saphenous Vein ( GSV ) insufficiency . One hundred fifty eligible patient recruit 6 month 9 study center follow period 3 year 7 visit day 8 , 6 week , 3 month , 6 month , 1,2 , 3 year . After randomization , patient treat echoguided sclerotherapy 1 % 3 % Lauromacrogol 400 foam ( ratio 1:1 ) . Monitoring perform doppler 8 day , 6 week , 6 month , 1,2 , 3 year . Effectiveness sclerotherapy determine 6 week , 3 month 6 month . A additional injection 4 ml foam perform need . Severity clinical score Quality-of-life questionnaire perform 6 month ,1 ,2 , 3 year . The absence obliteration reflux crural great saphenous vein 6 month criterion therapeutic failure . The therapeutic success failure criterion evaluate non investigator angiologist 5 patient randomized investigational site 1 , 2 3 year .</detailed_description>
	<mesh_term>Venous Insufficiency</mesh_term>
	<criteria>25 75 year Hawaii CEAP classification : C25 Ep , As23 Pr Clinical Varicose vein C2 , Edema C3 , Skin change C4 , Healed ulcer C5 Etiology Ep Primary GSV insufficiency As23 : Ostial crural truncular GVS incompetence Maximal inferior diameter leg GSV ( patient decubitus ) 4 8mm Pr : reflux echo doppler orthostatism &gt; 1 second Information consent form sign investigator patient . deep venous reflux ( CEAP : Ad ) Short saphenous vein non saphenous network insufficiency ( CEAP : A45 ) Clinical class : C1 C6 Recurrent GSV varicose vein strip Thrombophilia antecedent deep vein thrombosis Psychiatric disorder Known allergy Lauromacrogol one component Arteriopathy . ( IPS &lt; 0.8 ) Postthrombotic disease Chronic hepatoma Renal insufficiency ( creatinine &gt; 150 micromol/l )</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>lauromacrogol</keyword>
	<keyword>Sclerotherapy</keyword>
</DOC>